IntroductIon
Smoking, a major preventable cause of cardiovascular disease (CVD) and death, is associated with multiple derangements in cardiometabolic pathways. [1] [2] [3] [4] [5] For example, tobacco smoking is associated with lower body weight, 5 but higher waist circumference, suggesting a potential increase in the visceral fat. 2, 4 Prior studies have suggested that the metabolic changes in smoking may be mediated by adipokines, such as leptin, which is secreted from adipose tissue. 6 Although prior studies have demonstrated that higher leptin levels are associated with insulin resistance, atherosclerosis, and coronary artery disease, 7, 8 results are conflicting on the association between smoking and serum leptin, as a marker of cardiometabolic health and injury. [9] [10] [11] [12] [13] [14] [15] These discrepant results may
Multi-Ethnic Study of Atherosclerosis -Kianoush et al
be explained by differences in adipokine levels, particularly leptin, across racial/ethnic groups. 10, 11 Furthermore, the joint roles of abdominal fat, as the source of adipokines, in modifying or mediating the relationship between smoking and leptin levels are yet to be determined.
Prior studies included homogenous populations, were underpowcomplicated relationship between race/ethnicity, smoking, and smoking cessation on body composition, cardiometabolic health, and cardiovascular disease. These results may inform clinical guidelines and tobacco regulatory agencies in understanding whether there are higherrisk races/ethnicities, in whom the association between smoking and leptin -as a marker of cardiometabolic health -is more pronounced.
Methods

Participants
Design and methods of MESA have been described previously. 17 Briefly, MESA comprises 6,814 men and women of different races/ethnicities (White, Hispanic, African American, and Chinese American) enrolled from six different sites, all of whom were free of clinical CVD. A random subset of 1,875 participants, with available data related to smoking status, who underwent measurement of adipokine levels and abdominal CT scanning at examinations 2 or 3 (2002-2005) were included in our present study. All protocols were approved by the institutional review board at participating institutions and written informed consents were obtained from all participants.
Measurement of Covariates
Participants self-reported smoking exposure. The primary smoking variable was smoking status categorized as never, former, and current smoking. Never smoking was defined as lifetime use of less than 100 cigarettes. Former smokers had a previous history of smoking but had not consumed cigarettes within the last 30 days.
Stored fasting blood samples were used to measure leptin, adiponectin, and resistin levels by BioRad Luminex flow cytometry at the MESA central laboratory. Mean coefficients of variation across control samples were between 6.0-13.0%. 18 Anthropometric components were measured twice using standard protocols and the average was recorded. BMI was derived from weight (measured to the nearest .5 lb using a balance beam scale) and height (measured to the nearest .5 cm using a vertical ruler). Waist circumference was measured at the minimum abdominal circumference to the nearest .1 cm.
Electron-beam and multidetector CT scanners at Northwestern University, University of California, Columbia University, Wake Forest University, and University of Minnesota field centers were used to measure total abdominal, visceral, and internal abdominal fat and lean areas. Fat tissue was identified as being between -190 and -30 Hounsfield units (HU). Lean tissue was identified as being between 0 and 100 HU. Densities outside of these two ranges were labeled as undefined tissue type. Six transverse cross-sectional slices of data were assessed (2 at L2-3, 2 at L3-4, and 2 at L4-5 ered, or lacked accurate information regarding abdominal fat composition to show the role of race/ethnicity in the association between smoking and leptin levels. 9, 10, [13] [14] [15] [16] In our present study, using a large subset of individuals enrolled in Multi-Ethnic Study of Atherosclerosis (MESA), we aimed to assess the race/ethnicityspecific associations between smoking status (current, former, and never), leptin levels, and CT measures of total abdominal fat. Results from this study may shed light on the
Multi-Ethnic Study of Atherosclerosis -Kianoush et al
all measures. Information regarding settings, devices, and protocols were explained in detail previously.
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Data Analysis
We report mean ± standard deviation for normally distributed and median (interquartile range) for non-normally distributed baseline data, stratified by smoking status. We then compared absolute leptin levels by smoking status across categories of race/ethnicity. Using multivariable linear regression, we assessed the association between smoking status and log e -transformed fat and lean abdominal areas. Models were adjusted for sex, age, race/ethnicity, education, sedentary lifestyle, current alcohol use, triglyceride, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, diabetes mellitus, and lipid-lowering medications.
We used two multivariable linear regression models to evaluate the potential independent association between smoking status and log-transformed leptin (log e -leptin) levels. These included a baseline multivariable model (Model 1) and another model that was further adjusted for CT measures of total abdominal fat (Model 2).
Interaction terms between smoking status and sex, age, race/ethnicity in their associations with CT measures and adipokine levels were tested. In sensitivity analyses, we further adjusted for other measures of adiposity including BMI, waist circumference, and dietary patterns as well as inflammatory biomarkers such as high-sensitivity C-reactive protein (hsCRP) and tumor necrosis factor alpha (TNF-alpha). We used Stata 13 for all analyses. A two-sided P <.05 was considered significant.
results
Baseline characteristics of the 1,875 MESA participants (mean age 64.5 ± 9.6 years, 49.4% men, 42.2% former, 11.4% current smokers) are shown in Tables 1 and 2 , stratified according to smoking status. A total of 1,875 participants were included in our study, and 40.1% of participants were White, 25.8% Hispanic, 21.1% African American, and 13.0% Chinese American. Current smokers were younger (59.7 ± 8.6) than former (66.0 ± 9.2) and never smokers (64.3 ± 9.8). The prevalence of current smoking within groups was highest among African Americans (14.2%) and lowest among Figure 1 illustrates leptin levels by smoking status across racial/ethnic categories. Leptin levels were not different by smoking status among Whites (P= .73). Among African Americans, Hispanics, and Chinese Americans, former and current smokers had significantly lower leptin levels than never smokers (P<.001). The difference in median leptin levels between current and never smokers were Column percentages were used. Continuous variables are described as mean ± standard deviation or median (interquartile range). Categorical variables are described as number (percentage). Number may not sum up to total due to missing observations. Percentages may not sum up to 100% due to rounding. MESA, Multi-Ethnic Study of Atherosclerosis; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. 
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significantly higher for Hispanics (Δ9.64 ng/mL) and African Americans (Δ8.81 ng/mL) compared with Whites (Δ2.10 ng/mL) and Chinese (Δ4.70 ng/mL) (P<.001).
Multivariable linear regression models showed that, compared with never smokers, current smokers had significantly lower fat, but higher lean areas in total abdominal and visceral compartments (P<.05). Former smokers also had significantly higher lean areas in total abdominal and visceral compartments (P<.001). (Table 3 ) Table 4 shows results for the association between smoking status and log-leptin, stratified by race/ ethnicity. Multivariable linear regression models demonstrated that compared with never smokers, former and current smokers had lower log e -leptin without (Model 1) and with adjusting for CT measures of abdominal fat (Model 2). Log eleptin was not significantly different by smoking status among White and Chinese participants. Among Hispanics, log e -leptin was consistently lower among former smokers than never smokers in both models while among African Americans results were consistently significant for current smokers (P<.05). There were statistically significant interactions between smoking status and race with significantly lower log eleptin levels observed among African American current smokers (P=.048) as well as Hispanic former smokers (P=.025), compared with their never smoker counterparts.
There were no changes in the overall conclusions after adjusting for other measures of abdominal fat (BMI, and waist circumference, and CT measures of visceral fat) and dietary patterns in Model 1, and after adjusting for inflammatory markers (hsCRP and TNF-alpha) in Model 2. Also race/ethnicity-specific results were not significant for the association between other measures of smoking behavior, such as packyears of smoking, number of cigarettes smoke per day, and time since smoking cessation, and leptin levels. 
fat compared with never smokers, multivariable-adjusted leptin levels are lower in smokers vs never smokers accounting for various measures of body fat, including CT-measured abdominal fat, BMI, and waist circumference. However, we found marked race/ethnicity dimorphism in our results, with smoking associated with lower adjusted leptin levels in African Americans and Hispanics. Prior studies in different populations have reported that smoking is associated with lower, [20] [21] [22] [23] unchanged, 24, 25 or higher 26 leptin levels. For example, one small study comprising 236 Middle Eastern healthy participants, showed that smoking was associated with lower leptin levels. 10 Another study among 708 Japanese men reported that leptin levels were not affected by cigarette smoking. 25 Yet, another study including African and Australian participants suggested that smoking was associated with higher leptin levels. 26 Our results support the hypothesis that there are race-specific metabolic changes linked to smoking.
Our findings have clinical and research implications for smokers and those who have recently quit smoking with regard to body composition, ventive measures. As higher leptin is suggested to be associated with CVD, 7, 8 lower leptin levels in smokers vs non-smokers among African Americans and Hispanic suggest that other mechanisms play the predominant role for smoking-related cardiometabolic injury in these groups. On the contrary, White smokers had similar serum leptin levels compared with non-smokers (despite having lower total and visceral body fat) that may signify higher cardiometabolic risk from relative increase in leptin among former and current smokers in this group. White ever-smokers in particular may retain disordered metabolism and may benefit from strategies to reduce inflammation. However, additional larger studies are needed to evaluate and confirm the leptin-driven CVD risk across racial/ ethnic groups by smoking status.
The strengths of our study are the multi-ethnic/racial cohort and adjustment for various measures of body fat in our comprehensive anal- 
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